AI Outperforms Standard ECGs in Detecting Heart Attacks | ESC 2026

March 20, 2026 Ananya Mittal - World Editor

Artificial intelligence (AI) is showing promise in improving the speed and accuracy of heart attack diagnosis, potentially leading to faster treatment and better outcomes for patients. A study presented at the European Society of Cardiology’s ESC Acute CardioVascular Care 2026 conference demonstrated that AI-based interpretation of electrocardiograms (ECGs) surpassed traditional diagnostic methods in identifying a specific type of heart attack – occlusive myocardial infarction (MI).

Understanding Occlusive Myocardial Infarction

Myocardial infarction, commonly known as a heart attack, occurs when blood flow to a part of the heart is blocked, typically by a blood clot. An occlusive MI specifically refers to a complete blockage of a coronary artery. Quick and accurate diagnosis is crucial given that timely intervention – such as angioplasty or clot-busting medication – can minimize heart damage and save lives. An ECG, a non-invasive test that records the electrical activity of the heart, is a standard first-line diagnostic tool. However, interpreting ECGs can be challenging, even for experienced clinicians, and delays in diagnosis can occur.

The study, presented at the annual congress of the Association for Acute CardioVascular Care (ACVC), a branch of the European Society of Cardiology (ESC), suggests AI could help bridge this gap. The research focused on how well AI could detect occlusive MI from ECG readings compared to standard clinical practice.

How the AI System Performed

While specific details of the study – including the number of patients involved, the exact AI algorithms used, and the specific metrics for measuring performance – weren’t immediately available in the conference summary, the findings indicate a significant advantage for the AI-driven approach. The AI system demonstrated superior performance in identifying occlusive MI, suggesting it could reduce diagnostic delays and improve patient care.

It’s important to note that this research is still emerging. The presentation at ESC Acute CardioVascular Care 2026 represents an early step in evaluating the potential of AI in this critical area of cardiology. Further research, including larger clinical trials, will be needed to confirm these findings and determine how best to integrate AI into routine clinical practice.

Ventricular Septal Defects: A Complication of Heart Attacks

Heart attacks can sometimes lead to other serious complications. A recent review published in PubMed highlights the challenges surrounding ventricular septal defects (VSDs) that develop after a myocardial infarction. VSDs are holes in the wall separating the heart’s ventricles, and they can be life-threatening. The review emphasizes that these defects have a incredibly high mortality rate, even with surgical or interventional closure, and that more research is needed to determine the optimal treatment strategy. This underscores the complexity of heart attack care and the need for ongoing investigation into both prevention and management of complications.

The Role of Collaboration in Acute Cardiovascular Care

The theme of this year’s ESC Acute CardioVascular Care conference, “The Heart Team in Acute Cardiovascular Care,” highlights the importance of a collaborative approach to treating heart conditions. This includes physicians, nurses, allied health professionals, and specialists working together to provide comprehensive care. AI, isn’t intended to replace clinicians, but rather to augment their abilities and improve the efficiency of the diagnostic process. The conference emphasized that teamwork drives progress, and that dynamic, hands-on training – like simulations and workshops – are essential for translating scientific advancements into practical skills.

Current Guidance on Managing Cardiogenic Shock

Relatedly, the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the management of patients with cardiogenic shock, a severe condition often resulting from heart attacks, acknowledges the potential benefits of certain mechanical support devices. Specifically, the guideline states that using a microaxial flow pump in selected patients with cardiogenic shock related to acute myocardial infarction is “reasonable” to reduce death. However, it as well cautions that these pumps are associated with higher rates of complications like bleeding, limb ischemia, and renal failure compared to standard care. This illustrates the careful balance between potential benefits and risks that clinicians must consider when making treatment decisions.

What Comes Next: Refining AI and Expanding Research

The promising results from the ESC Acute CardioVascular Care 2026 presentation will likely spur further research into the use of AI in ECG interpretation. Key areas of focus will include:

  • Larger Clinical Trials: Conducting studies with more patients and diverse populations to validate the AI’s performance across different settings.
  • Algorithm Refinement: Improving the accuracy and robustness of the AI algorithms through ongoing training and optimization.
  • Integration into Clinical Workflows: Developing practical strategies for seamlessly integrating AI into existing hospital systems and emergency response protocols.
  • Addressing Bias: Ensuring that AI algorithms are free from bias and perform equally well across all demographic groups.

The ultimate goal is to create AI-powered tools that can assist clinicians in making faster, more accurate diagnoses, ultimately leading to improved outcomes for patients experiencing heart attacks. The ongoing research and collaborative efforts within the cardiovascular community are essential steps towards realizing this potential.